Arbe Robotics Ltd.
ARBETechnologyNASDAQScientific & Technical Instruments · Last scanned Sep 7, 2026
Scan Results
Daily timeframePart of the technology sector, Arbe Robotics Ltd. (ARBE) is listed under Scientific & Technical Instruments. The company carries a $81.0M market cap, placing it firmly in the micro-cap category. It offers a radar chipset, including transmitter (Tx), receiver (Rx), and processor chips; and the Phoenix perception radar for free space mapping, object tracking, and simultaneous localization and mapping.
Market Cap
$81.0M
Beta
1.12
P/E (TTM)
—
P/E (Fwd)
-4.24
EPS (TTM)
$-0.34
EPS (Fwd)
$-0.15
ROE
-83.2%
ROA
-37.6%
Cash
$41.6M
Total Debt
$25.9M
Free CF
-$38.4M
52W Change
-51.1%
Annual Financials
Cash vs Debt
Where ARBE stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ARBE finished 25.00% below its 150-day moving average ($0.84) and 34.37% below its 200-day moving average ($0.96). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ARBE overbought or oversold?
At the September 3, 2026 close, ARBE's RSI(14) was 25.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $41.6M in cash comfortably exceeding the $25.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow is running at -$38.4M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -83.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $3.5M (2022) to $1.0M (2025), a 71% decline worth watching.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ARBE.